Zentalis Pharmaceuticals (ZNTL)

Zeno Management, Inc. • Zeno Pharmaceuticals, Inc. • Zeno Alpha, Inc. • K-Group Alpha, Inc. • K-Group Beta, Inc. • Zentalis Pharmaceuticals Australia Pty Ltd. ...

ZNTL stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$6.07

Low target

$2.20

High target

$10.00

Latest filings (excl ownership)

View all

8-K

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

29 Jan 25

8-K

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development

28 Jan 25

8-K/A

Departure of Directors or Certain Officers

19 Dec 24

8-K

Zentalis Pharmaceuticals Announces Executive Leadership Changes Supporting Planned Registrational Clinical Studies of Azenosertib

12 Nov 24

Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies

9 Aug 24

Zentalis Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Progress

9 Aug 24

8-K

Submission of Matters to a Vote of Security Holders

21 Jun 24

8-K

Regulation FD Disclosure

3 Jun 24

Latest ownership filings

View all

SC 13G/A

EVENTIDE ASSET MANAGEMENT, LLC

Notice of proposed sale of securities

Luke Nathaniel Walker

4 Feb 25

Financial summary

Financial statements Chart ZNTL financial data

Quarter (USD)	Sep 24	Jun 24	Mar 24	Dec 23
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	43.95 mm	43.95 mm	43.95 mm	43.95 mm	43.95 mm	43.95 mm
Cash burn (monthly)	(no burn)	5.79 mm	17.14 mm	17.44 mm	14.68 mm	14.31 mm
Cash used (since last report)	n/a	27.36 mm	81.06 mm	82.46 mm	69.42 mm	67.68 mm
Cash remaining	n/a	16.59 mm	-37.12 mm	-38.51 mm	-25.47 mm	-23.73 mm
Runway (months of cash)	n/a	2.9	-2.2	-2.2	-1.7	-1.7

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

ZNTL institutional ownership history Ownership history

99.6% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	135	141	-4.3%
Opened positions	29	31	-6.5%
Closed positions	35	26	+34.6%
Increased positions	45	53	-15.1%
Reduced positions	39	39	–

13F shares	Current	Prev Q	Change
Total value	252.64 bn	302.44 bn	-16.5%
Total shares	70.95 mm	76.61 mm	-7.4%
Total puts	89.60 k	6.60 k	+1257.6%
Total calls	48.50 k	61.80 k	-21.5%
Total put/call ratio	1.8	0.1	+1629.9%

Largest owners	Shares	Value	Change
Matrix Capital Management	13.96 mm	$51.37 bn	0.0%
Eventide Asset Managment	8.55 mm	$31.46 bn	0.0%
FMR	5.08 mm	$18.68 bn	-41.5%
BlackRock	4.76 mm	$17.52 bn	NEW
Vanguard	4.61 mm	$16.97 bn	-18.4%
Decheng Capital	3.11 mm	$11.44 bn	+1.2%
Citadel Advisors	2.72 mm	$10.00 bn	-39.6%
MS Morgan Stanley	1.61 mm	$5.93 bn	-17.4%
Verition Fund Management	1.50 mm	$5.54 bn	+172.1%
Primecap Management	1.50 mm	$5.51 bn	+21.6%

Largest transactions	Shares	Bought/sold	Change
BLK BlackRock	0.00	-4.82 mm	EXIT
BlackRock	4.76 mm	+4.76 mm	NEW
FMR	5.08 mm	-3.60 mm	-41.5%
STT State Street	1.25 mm	-1.81 mm	-59.2%
Citadel Advisors	2.72 mm	-1.79 mm	-39.6%
T. Rowe Price Investment Management	0.00	-1.33 mm	EXIT
Vanguard	4.61 mm	-1.04 mm	-18.4%
Opaleye Management	967.00 k	+967.00 k	NEW
Almitas Capital	960.93 k	+960.93 k	NEW
Verition Fund Management	1.50 mm	+951.50 k	+172.1%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ZNTL insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
6 Feb 25	Ingmar Bruns	Common Stock	Buy	Acquire P	No	No	2.2828	20,000	45.66 k	36,629
3 Feb 25	Eastland Julia Marie	Common Stock	Grant	Acquire A	No	No	0	59,388	0.00	87,888
3 Feb 25	Eastland Julia Marie	Stock Option Common Stock	Grant	Acquire A	No	No	1.68	59,388	99.77 k	59,388
3 Feb 25	Ingmar Bruns	Common Stock	Grant	Acquire A	No	No	0	16,629	0.00	16,629
3 Feb 25	Ingmar Bruns	Stock Option Common Stock	Grant	Acquire A	No	No	1.68	16,629	27.94 k	16,629
3 Feb 25	Lackner Mark	Common Stock	Sell	Dispose S	No	No	1.7115	14,368	24.59 k	512,856
3 Feb 25	Lackner Mark	Common Stock	Grant	Acquire A	No	No	0	335,907	0.00	527,224
3 Feb 25	Lackner Mark	Stock Option Common Stock	Grant	Acquire A	No	No	1.68	124,714	209.52 k	124,714
3 Feb 25	Andrea Paul	Common Stock	Sell	Dispose S	No	No	1.7115	13,230	22.64 k	1,070,784
3 Feb 25	Andrea Paul	Common Stock	Grant	Acquire A	No	No	0	934,041	0.00	1,084,014